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Hemorrhage due to radiation-
induced sarcoma of the
mandible: Treatment with
percutaneous cryotherapy
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Several  treatment  options  are  currently  available  for
tumors  causing  repeated  moderate  or  severe  bleeding.  After
failure  of  local  medical  treatments,  surgical  ligation  of  the
feeding  arteries  should  be  considered.  Percutaneous  arte-
rial  embolization  is  also  a  technique  of  choice,  which  can  be
performed  in  the  interventional  radiology  suite  [1].  In  these
situations,  percutaneous  treatments  under  radiological  con-
trol,  such  as  sclerotherapy  and  cryotherapy,  are  now  in  full
development  [2].
Cryotherapy  is  currently  regarded  as  a  curative  method,
either  for  percutaneous  destruction  of  tumors  and  for  pallia-
tive  and  analgesic  purposes.  The  advantage  of  cryotherapy
is  that  it  is  a  minimally  invasive  and  relatively  painless  pro-
cedure  that  carries  little  risk  [3].
We  describe  herein  the  ﬁrst  reported  case  on  the  use  of
cryotherapy  for  hemostatic  purposes  in  oncology.
Case  report
A  67-year-old  woman  with  a  past  history  of  squamous  cell
carcinoma  of  the  right  lateral  edge  of  the  tongue,  treated
ten  years  before  with  pelviglossomandibulectomy  and
radiotherapy,  has  been  followed  up  for  ﬁve  years  for  radio-
induced  sarcoma  in  contact  with  the  right  horizontal  branch
of  the  mandible.  The  patient  was  in  the  palliative  phase
and  had  prior  repeated  episodes  of  endobuccal  bleeding
at  the  tumor  site  complicated  by  chronic  anemia.  Cervico-
facial  computed  tomography  (CT)  examination  before  and
after  intravenous  administration  of  iodinated  contrast  mate-
rial  identiﬁed  a  vascular  nidus  in  the  mandibular  sarcoma
with  no  extravasation  (Fig.  1).  A  tight  stenosis  >  80%  in  the
ipsilateral  common  carotid  artery  was  present  (Fig.  2).
Because  of  symptoms  of  repeated  bleeding  and  their
clinical  consequences,  selective  embolization  of  the  tumor
site  was  discussed  during  a  multidisciplinary  meeting.  This
procedure  however  was  contraindicated  because  of  the  tight
ipsilateral  common  carotid  artery  stenosis.  In  the  same  time,
surgery  was  not  considered  because  of  the  patient’s  general
condition  and  the  inﬁltrative  hypervascular  nature  of  the
sarcoma.  Hemostatic  percutaneous  cryotherapy  centered  on
the  tumor  vascular  nidus  under  neuroleptic  analgesia  was
n
n
o
ahus  decided  because  no  alternate  treatment  options  could
e  performed.
The  procedure  was  performed  under  conscious  sedation.
 landmark  image  was  deﬁned  on  enhanced  CT-scan  (Fig.  1)
o  identify  the  target  area,  with  a  vascular  bundle  in  the
umor  area.  After  local  anesthesia  using  a  22-G  needle,  a
ryotherapy  needle  (Ice  Seed® Cryoprobe,  Galil  Medical,
rden  Hills,  MN,  USA)  was  positioned  under  CT  guidance  into
he  hypervascular  area  that  was  assumed  to  be  at  risk  of
leeding  (Fig.  3).  A  right  inferior  mandibular  angle  approach
as  chosen  because  of  a direct  access  to  the  selected  target
nd  no  needle  repositioning  was  needed.  The  skin  was  pro-
ected  with  a  warm  water  bag  to  avoid  any  freezing-induced
amage.  Cryoablation  treatment  was  performed  with  two
omplete  cycles  of  freezing  of  10  minutes  each  separated
y  a  10  minute  thawing  (9  minutes  passive  and  one  minute
ctive).  The  total  cryoablation  time  was  40  minutes.  Dur-
ng  the  freezing  phase  a  control  image  was  obtained  at
 minutes  cooling  in  each  cycle  to  visualize  and  monitor  ice
ormation  and  check  for  correct  positioning  of  the  needle.
he  Ice  Seed® needle  was  gently  removed  after  control  CT
xamination.  During  the  immediate  postoperative  period,
he  patient  was  given  analgesic  drugs  for  three  days  but
o  other  measures  were  taken.  No  hematoma  formation,
o  postoperative  edema  or  pain  was  reported  following  the
rocedure.  The  skin  condition  was  preserved  by  placing  a
arm  water  bag  on  the  skin  located  adjacent  to  the  cooling
rea.
The  patient  was  clinically  evaluated  at  15  days  postop-
rative  and  then  at  one  and  six  months  after  the  procedure.
he  reported  no  further  bleeding.  Skin  condition  was  entirely
reserved.  In  the  same  time,  repeat  CT  two  after  the  proce-
ure  showed  no  complications  due  to  cryotherapy  (Fig.  4).
iscussion
here  are  different  alternative  treatments  for  a  tumor  caus-
ng  repeated  moderate  or  severe  bleeding  [1].  After  medical
reatments  (local  care)  have  failed  to  stem  the  bleeding,
urgery  is  the  conventional  technique  with  ligation  of  the
eeder  arteries  responsible  for  the  bleed.  Percutaneous
ndovascular  arterial  embolization  is  also  a  technique  of
hoice  which  can  be  performed  in  the  interventional  radiol-
gy  suite.
In  our  patient,  however,  the  patient’s  general  condition,
nesthetic  risk  and  the  inﬁltrative  and  hypervascularized
ature  of  the  tumor  made  surgery  impossible.  Percuta-
eous  arterial  embolization  was  also  disregarded  because
f  an  ipsilateral  common  carotid  artery  stenosis  which  made
ccess  to  the  artery  responsible  for  the  bleeding  impossible.
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Figure 1. a: CT-scan in the axial plane at the level of radio-induced sarcoma located on the right horizontal branch of the mandible shows
the vascular nidus arising from the right external carotid artery (arrow); b: CT-scan in the sagittal plane at the level of the right horizontal
branch of the mandible shows heterogeneous mass with blurred outlines and a vascular nidus arising from the right external carotid artery
(arrow).
Figure 2. CT-scan in the coronal plane obtained during the arte-
rial phase of injection with 5 mm MIP reconstruction passing through
the right common carotid artery shows tight (> 80%) stenosis of right
carotid artery (arrow).
Figure 3. Per-procedure control CT image during the ﬁrst
cryotherapy cycle shows Ice Seed® needle correctly positioned in
the vascular nidus of the tumor with ice formation (arrow).
F
c
b
L
q
t
a
o
b
‘
c
f
a
c
t
w
t
wigure 4. Repeat CT in the axial plane two months after the pro-
edure shows loco-regional tumor growth in the right ascending
ranch of the mandible.
ocal  care  was  insufﬁcient  because  of  the  clinical  conse-
uences  of  the  chronic  bleeding.
Cryotherapy  consists  in  the  application  of  extremely  low
emperature  focused  on  target  tumor  tissues  in  order  to
chieve  a  cytotoxic  effect.  The  effect  on  tissues  mostly
ccurs  when  target  temperature  reaches  —40  to  —20 ◦C
y  intracellular  ice  formation.  Osmotic  changes  during  the
‘freezing-thawing-freezing’’  cycle  lead  to  rupture  of  the
ell  walls  and  further  apoptosis.  Cryotherapy  is  mostly  used
or  therapeutic  or  palliative  analgesic  purposes.
A  literature  search  disclosed  two  cases  in  which  cryother-
py  has  been  used  to  treat  a  maxillo-facial  hemangioma
omplicated  by  repeated  bleeding  [4,5]. In  these  two  cases,
he  treatment  of  the  venous  malformations  was  successful
ith  no  reported  postoperative  complications  and  stopped
he  bleeding  due  to  venous  malformations.
In  our  patient,  the  beneﬁts  of  cryotherapy  were  that  it
as  minimally  invasive,  relatively  painless  and  carried  little
[[
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risk  [3,6].  In  addition,  the  ice  is  visible  on  repeat  CT  con-
trols,  thus  allowing  a  limited  size  of  frozen  ice  region  located
in  the  area  being  treated  and  preserving  important  struc-
tures  (skin,  vessels  and  nerves)  and  reducing  side  effects,
particularly  post-procedure  inﬂammation.
In  conclusion,  we  have  reported  the  ﬁrst  use  of  cryother-
apy  as  a  treatment  option  for  recurrent  tumor  bleeding.  This
treatment  appears  to  be  effective,  with  a  low  complication
rate.  Our  observation  suggests  that  it  should  be  considered
as  an  alternate  option  to  surgery  and  percutaneous  arterial
embolization  in  highly  selected  patients.
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